Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 6 April 1990:
Vol. 248. no. 4951, pp. 79 - 83
DOI: 10.1126/science.2181668
Prev | Table of Contents | Next

Articles

Science, Vol 248, Issue 4951, 79-83
Copyright © 1990 by American Association for the Advancement of Science

articles

EGF receptor and erbB-2 tyrosine kinase domains confer cell specificity for mitogenic signaling

PP Di Fiore, O Segatto, WG Taylor, SA Aaronson, and JH Pierce

Laboratory of Cellular and Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.

The epidermal growth factor (EGF) receptor (EGFR) can efficiently couple with mitogenic signaling pathways when it is transfected into interleukin-3 (IL-3)-dependent 32D hematopoietic cells. When expression vectors for erbB-2, which is structurally related to EGFR, or its truncated counterpart, delta NerbB-2, were introduced into 32D cells, neither was capable of inducing proliferation. This was despite overexpression and constitutive tyrosine kinase activity of their products at levels associated with potent transformation of fibroblast target cells. Thus, EGFR and erbB-2 couple with distinct mitogenic signaling pathways. The region responsible for the specificity of intracellular signal transduction was localized to a 270-amino acid stretch encompassing their respective tyrosine kinase domains. Thus, tissue- or cell-specific regulation of growth factor receptor signaling can occur at a point after the initial interaction of growth factor with receptor. Such specificity in signal transduction may account for the selection of certain oncogenes in some malignancies.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Thyroid Hormone Receptor {beta}1 Acts as a Potent Suppressor of Tumor Invasiveness and Metastasis.
O. Martinez-Iglesias, S. Garcia-Silva, S. P. Tenbaum, J. Regadera, F. Larcher, J. M. Paramio, B. Vennstrom, and A. Aranda (2009)
Cancer Res. 69, 501-509
   Abstract »    Full Text »    PDF »
Epidermal growth factor-stimulated extravillous cytotrophoblast motility is mediated by the activation of PI3-K, Akt and both p38 and p42/44 mitogen-activated protein kinases.
H. L. LaMarca, P. R. Dash, K. Vishnuthevan, E. Harvey, D. E. Sullivan, C. A. Morris, and G. St. J. Whitley (2008)
Hum. Reprod. 23, 1733-1741
   Abstract »    Full Text »    PDF »
Modeling Breast Cancer-Associated c-Src and EGFR Overexpression in Human MECs: c-Src and EGFR Cooperatively Promote Aberrant Three-dimensional Acinar Structure and Invasive Behavior.
M. Dimri, M. Naramura, L. Duan, J. Chen, C. Ortega-Cava, G. Chen, R. Goswami, N. Fernandes, Q. Gao, G. P. Dimri, et al. (2007)
Cancer Res. 67, 4164-4172
   Abstract »    Full Text »    PDF »
Targeted Antireceptor Therapy with Monoclonal Antibodies Leads to the Formation of Inactivated Tetrameric Forms of ErbB Receptors.
K. Furuuchi, A. Berezov, T. Kumagai, and M. I. Greene (2007)
J. Immunol. 178, 1021-1029
   Abstract »    Full Text »    PDF »
Association with HSP90 Inhibits Cbl-Mediated Down-regulation of Mutant Epidermal Growth Factor Receptors..
S. Yang, S. Qu, M. Perez-Tores, A. Sawai, N. Rosen, D. B. Solit, and C. L. Arteaga (2006)
Cancer Res. 66, 6990-6997
   Abstract »    Full Text »    PDF »
Timely DNA Vaccine Combined with Systemic IL-12 Prevents Parotid Carcinomas before a Dominant-Negative p53 Makes Their Growth Independent of HER-2/neu Expression..
T. Pannellini, M. Spadaro, E. Di Carlo, E. Ambrosino, M. Iezzi, A. Amici, P. L. Lollini, G. Forni, F. Cavallo, and P. Musiani (2006)
J. Immunol. 176, 7695-7703
   Abstract »    Full Text »    PDF »
Controlled Activation of ErbB1/ErbB2 Heterodimers Promote Invasion of Three-Dimensional Organized Epithelia in an ErbB1-Dependent Manner: Implications for Progression of ErbB2-Overexpressing Tumors..
L. Zhan, B. Xiang, and S. K. Muthuswamy (2006)
Cancer Res. 66, 5201-5208
   Abstract »    Full Text »    PDF »
ZD6474, an Orally Available Inhibitor of KDR Tyrosine Kinase Activity, Efficiently Blocks Oncogenic RET Kinases.
F. Carlomagno, D. Vitagliano, T. Guida, F. Ciardiello, G. Tortora, G. Vecchio, A. J. Ryan, G. Fontanini, A. Fusco, and M. Santoro (2002)
Cancer Res. 62, 7284-7290
   Abstract »    Full Text »    PDF »
Second Cysteine-rich Region of Epidermal Growth Factor Receptor Contains Targeting Information for Caveolae/Rafts.
M. Yamabhai and R. G. W. Anderson (2002)
J. Biol. Chem. 277, 24843-24846
   Abstract »    Full Text »    PDF »
Mer Receptor Tyrosine Kinase Signaling. PREVENTION OF APOPTOSIS AND ALTERATION OF CYTOSKELETAL ARCHITECTURE WITHOUT STIMULATION OR PROLIFERATION.
K. L. Guttridge, J. C. Luft, T. L. Dawson, E. Kozlowska, N. P. Mahajan, B. Varnum, and H. S. Earp (2002)
J. Biol. Chem. 277, 24057-24066
   Abstract »    Full Text »    PDF »
The Kinase Inhibitor PP1 Blocks Tumorigenesis Induced by RET Oncogenes.
F. Carlomagno, D. Vitagliano, T. Guida, M. Napolitano, G. Vecchio, A. Fusco, A. Gazit, A. Levitzki, and M. Santoro (2002)
Cancer Res. 62, 1077-1082
   Abstract »    Full Text »    PDF »
Bombesin-like peptides and receptors in normal fetal baboon lung: roles in lung growth and maturation.
R. L. Emanuel, J. S. Torday, Q. Mu, N. Asokananthan, K. A. Sikorski, and M. E. Sunday (1999)
Am J Physiol Lung Cell Mol Physiol 277, L1003-L1017
   Abstract »    Full Text »    PDF »
Controlled Dimerization of ErbB Receptors Provides Evidence for Differential Signaling by Homo- and Heterodimers.
S. K. Muthuswamy, M. Gilman, and J. S. Brugge (1999)
Mol. Cell. Biol. 19, 6845-6857
   Abstract »    Full Text »    PDF »
Ribozyme-mediated Down-Regulation of ErbB-4 in Estrogen Receptor-positive Breast Cancer Cells Inhibits Proliferation Both in Vitro and in Vivo.
C. K. Tang, X.-Z. W. Concepcion, M. Milan, X. Gong, E. Montgomery, and M. E. Lippman (1999)
Cancer Res. 59, 5315-5322
   Abstract »    Full Text »    PDF »
The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor.
J. K. Doherty, C. Bond, A. Jardim, J. P. Adelman, and G. M. Clinton (1999)
PNAS 96, 10869-10874
   Abstract »    Full Text »    PDF »
Ret-mediated Mitogenesis Requires Src Kinase Activity.
R. M. Melillo, M. V. Barone, G. Lupoli, A. M. Cirafici, F. Carlomagno, R. Visconti, B. Matoskova, P. P. Di Fiore, G. Vecchio, A. Fusco, et al. (1999)
Cancer Res. 59, 1120-1126
   Abstract »    Full Text »    PDF »
Interleukin 12-mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice.
K. Boggio, G. Nicoletti, E. Di Carlo, F. Cavallo, L. Landuzzi, C. Melani, M. Giovarelli, I. Rossi, P. Nanni, C. De Giovanni, et al. (1998)
J. Exp. Med. 188, 589-596
   Abstract »    Full Text »    PDF »
ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through ErbB4.
L.-M. Wang, A. Kuo, M. Alimandi, M. C. Veri, C.-C. Lee, V. Kapoor, N. Ellmore, X.-H. Chen, and J. H. Pierce (1998)
PNAS 95, 6809-6814
   Abstract »    Full Text »    PDF »
Analysis of Grb7 Recruitment by Heregulin-activated erbB Receptors Reveals a Novel Target Selectivity for erbB3.
R. J. Fiddes, D. H. Campbell, P. W. Janes, S. P. Sivertsen, H. Sasaki, C. Wallasch, and R. J. Daly (1998)
J. Biol. Chem. 273, 7717-7724
   Abstract »    Full Text »    PDF »
Association of Csk-homologous Kinase (CHK) (formerly MATK) with HER-2/ErbB-2 in Breast Cancer Cells.
S. Zrihan-Licht, J. Lim, I. Keydar, M. X. Sliwkowski, J. E. Groopman, and H. Avraham (1997)
J. Biol. Chem. 272, 1856-1863
   Abstract »    Full Text »    PDF »
The Epidermal Growth Factor Receptor Couples Transforming Growth Factor-alpha , Heparin-binding Epidermal Growth Factor-like Factor, and Amphiregulin to Neu, ErbB-3, and ErbB-4.
D. J. Riese II, E. D. Kim, K. Elenius, S. Buckley, M. Klagsbrun, G. D. Plowman, and D. F. Stern (1996)
J. Biol. Chem. 271, 20047-20052
   Abstract »    Full Text »    PDF »
HER4-mediated Biological and Biochemical Properties in NIH 3T3 Cells.
B. D. Cohen, J. M. Green, L. Foy, and H. P. Fell (1996)
J. Biol. Chem. 271, 4813-4818
   Abstract »    Full Text »    PDF »
Identification of Anaplastic Lymphoma Kinase as a Receptor for the Growth Factor Pleiotrophin.
G. E. Stoica, A. Kuo, A. Aigner, I. Sunitha, B. Souttou, C. Malerczyk, D. J. Caughey, D. Wen, A. Karavanov, A. T. Riegel, et al. (2001)
J. Biol. Chem. 276, 16772-16779
   Abstract »    Full Text »    PDF »
Epidermal Growth Factor (EGF) Receptor Kinase-independent Signaling by EGF.
T. B. Deb, L. Su, L. Wong, E. Bonvini, A. Wells, M. David, and G. R. Johnson (2001)
J. Biol. Chem. 276, 15554-15560
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)